Track this trial free. DataLookout checks ClinicalTrials.gov daily and emails you which fields changed on NCT07600177 (status, enrollment, completion dates, endpoints, sites) when this record is updated. Free accounts track up to 5 trials.

Track this trial

Mavacamten to Aficamten Transition in Patients With Obstructive Hypertrophic Cardiomyopathy

Study acronym: CMI-SWITCH
StatusRecruiting
PhasePhase 4
Started
View on ClinicalTrials.gov ↗

Record History

  1. Study First Submitted
This is an investigator-initiated two-center study. The goal of this study is to investigate the feasibility, safety and efficacy outcomes of a seamless transition from mavacamten to aficamten in patients with obstructive hypertrophic cardiomyopathy (oHCM).
Trial Details
NCT Number NCT07600177
Lead Sponsor Oregon Health and Science University
Collaborators: Saint Lukes Hospital Mid America Heart Institute, Cytokinetics
Conditions
(from sponsor)		 Hypertrophic Cardiomyopathy (HCM)
Related terms Cardiomyopathy, Hypertrophic
Enrollment 40 participants
Start Date
Primary Completion (estimated)
Study Completion (estimated)
Updated on ClinicalTrials.gov